C
Cartesian Therapeutics, Inc. (RNAC)
NGM – Real vaqt narxi. Valyuta: USD
5.85
-0.23 (-3.78%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
5.83
-0.02 (-0.34%)
Bozordan keyin: Mar 27, 2026, 4:18 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NGM – Real vaqt narxi. Valyuta: USD
5.85
-0.23 (-3.78%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
5.83
-0.02 (-0.34%)
Bozordan keyin: Mar 27, 2026, 4:18 PM EDT
Cartesian Therapeutics, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, autoimmun kasalliklarni davolash uchun mRNK hujayrali terapiyasini taqdim etadi. Kompaniyaning asosiy mahsulot nomzodlari Descartes-08 hisoblanadi, bu B-hujayra etuklik antigenga (BCMA) qarshi yo'naltirilgan avtolog mRNK ximerik antigen retseptorli T-hujayrali terapiyasi (CAR-T) bo'lib, u autoimmun kasalliklar, umumiy miyasteniya gravis va tizimli qizil yug'rikni davolash uchun 2b-bosqich klinik sinovlarida, shuningdek, infantil dermatomiyozitni davolash uchun noyob pediatrik kasallik sifatida belgilangan. Kompaniya, shuningdek, Descartes-15ni ishlab chiqmoqda, bu esa 1-bosqich sinovlarida, ko'p miyelomali bemorlarni davolash uchun avtolog B-hujayra etuklik antigenga (BCMA) yo'naltirilgan mRNK CAR-T hisoblanadi. Kompaniyaning shtab-kvartirasi Frederik, Merilendda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Carsten Brunn Ph.D. | President, CEO & Chairman of the Board |
| Dr. Emily English Ph.D. | Chief Operating Officer |
| Dr. Metin Kurtoglu M.D., Ph.D. | Consultant |
| Dr. Milos Miljkovic M.D., Ph.D. | Chief Medical Officer |
| Mr. Blaine T. Davis | Chief Financial Officer |
| Mr. Matthew Bartholomae J.D. | General Counsel & Secretary |
| Ms. June Seymour | Chief Accounting Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-09 | 8-K | rnac-20260309.htm |
| 2026-01-09 | 8-K | rnac-20260109.htm |
| 2025-12-18 | 8-K | rnac-20251216.htm |
| 2025-11-13 | 8-K | rnac-20251113.htm |
| 2025-11-06 | 8-K | rnac-20251106.htm |
| 2025-10-30 | 8-K | ef20057980_8k.htm |
| 2025-10-21 | 8-K | rnac-20251015.htm |
| 2025-10-08 | 8-K | rnac-20251002.htm |
| 2025-08-07 | 10-Q | rnac-20250630.htm |
| 2025-06-16 | 8-K | rnac-20250613.htm |